We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

In-house Produced PMMA- Versus PEEK-cages (Palcage)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01607775
First Posted: May 30, 2012
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Martin Barth, MD, University Hospital Mannheim
  Purpose
Subsidence of cervical cages is a common problem. For the study, a new polyacrylmethacrylate cage was designed and prospectively implanted in patients with a mono- or bilevel cervical pathology. As control, a commercially available PEEK-cage was used, patients were randomized using minimization randomization, controlling for age and bone mineral densitiy. The investigators hypothesize that the newly developed cage has similar clinical and radiological qualities compared to the PEEK-cage, but at a much more favourable cost-performance ratio.

Condition Intervention Phase
Cervical Disc Degeneration Cervical Stenosis Device: Implantation of a PEEK-cage Device: PMMA-cage Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Characterization of In-house Produced PMMA-cages in Patients With Cervical Pathology

Resource links provided by NLM:


Further study details as provided by Martin Barth, MD, University Hospital Mannheim:

Primary Outcome Measures:
  • Clinical outcome (NDI) [ Time Frame: 12 months postoperative ]
    NDI (Neck disability index) will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).


Secondary Outcome Measures:
  • Clinical outcome (VAS-neck), Subsidence [ Time Frame: 12 months postoperative ]
    1. VAS-neck will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).
    2. Cage Subsidence will be measured using lateral radiographs prior to surgery and 12 months after surgery. Due to an improved cage design, significantly less subsidence is proposed for the experimental implant (PMMA-cage).


Enrollment: 88
Study Start Date: February 2009
Study Completion Date: February 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: PEEK-cage
Patients will receive a PEEK-cage
Device: Implantation of a PEEK-cage
A commercially avaliable cuboid cervical cage will be implantet
Experimental: PMMA-cage Device: PMMA-cage
The in-house produced cervical cage will be implanted

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • virgin spines
  • no emergency operation
  • age above 18
  • sufficient knowledge of the German language
  • indication for anterior cervical discectomy and fusion
  • absence of concomitant spinal disease

Exclusion Criteria:

  • prior cervical surgery
  • indications other than ACDF
  • concomitant neoplastic, metabolic, severe general or infectious disease
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Martin Barth, MD, M. D., Vice-chairman, University Hospital Mannheim
ClinicalTrials.gov Identifier: NCT01607775     History of Changes
Other Study ID Numbers: 2007-256M-MA
First Submitted: May 22, 2012
First Posted: May 30, 2012
Last Update Posted: October 12, 2017
Last Verified: June 2012

Additional relevant MeSH terms:
Intervertebral Disc Degeneration
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases